good reply, keep it quite and let the market decide what's the best course of action.
you are a Pharma company and not here to please anybody.
if anyone has to explain its Culper or Acadia.
don't loose your focus John and management, a lot to do!.
Ann: Comment on research report, page-32
-
- There are more pages in this discussion • 285 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$15.18 |
Change
-0.300(1.94%) |
Mkt cap ! $1.940B | |||
| Open | High | Low | Value | Volume |
| $15.20 | $15.33 | $15.02 | $3.293M | 216.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 10 | 352 | $15.18 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $15.20 | 520 | 9 |
View Market Depth
| Last trade - 12.30pm 22/08/2024 (20 minute delay) ? |
| NEU (ASX) Chart |